News from us and our partners

Tags

Topics

0 results

News
22 April, 2020
Nitrome Biosciences Raises $38M Series A Financing to Advance Therapeutics Targeting a Novel Group of Enzymes involved in Age-related Diseases
News
20 April, 2020
Sofinnova Partners Announces Third Investment from its Italian Fund
News
20 April, 2020
Pi-Cardia Closes a $27 Million Financing led by Sofinnova Partners to Continue Clinical Trials With Its Leaflex™ Aortic Valve Technology
News
20 April, 2020
Biotalys establishes Scientific Advisory Board
News
16 April, 2020
RefleXion Raises $100 Million for Cancer Treatment Commercialization
News
15 April, 2020
GenSight Biologics on Track to Submit LUMEVOQ® for European Approval in September 2020 Following Pre-Submission Meeting with EMA
News
14 April, 2020
EryDel Announces Completion of Patient Enrollment in Phase 3 ATTeST Trial the Largest Clinical Study Ever Conducted in Ataxia Telangiectasia (AT)
News
13 April, 2020
Shockwave Completes Enrollment of Coronary Intravascular Lithotripsy Study in Japan
News
9 April, 2020
Calliditas Appoints New Chief Medical Officer
News
9 April, 2020
RefleXion Announces First Sale of X1 Machine for Cancer Treatment
News
7 April, 2020
Shockwave Completes Enrollment in Pivotal Study for Coronary Intravascular Lithotripsy
News
3 April, 2020
Tissium Receives CE Mark and Announces Manufacturing Compliance Certification from TÜV SÜD
News
2 April, 2020
Calliditas strengthens its US Commercial Organization
News
31 March, 2020
Pixium Vision announces positive follow-up data from Prima System study in dry AMD
News
31 March, 2020
ProQR Announces Positive Findings From an Interim Analysis in the Phase 1/2 trial of QR-421a for Usher Syndrome and Provides Business Update
News
31 March, 2020
Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines

Nitrome Biosciences Raises $38M Series A Financing to Advance Therapeutics Targeting a Novel Group of Enzymes involved in Age-related Diseases

Sofinnova Partners Announces Third Investment from its Italian Fund

Pi-Cardia Closes a $27 Million Financing led by Sofinnova Partners to Continue Clinical Trials With Its Leaflex™ Aortic Valve Technology

Biotalys establishes Scientific Advisory Board

RefleXion Raises $100 Million for Cancer Treatment Commercialization

GenSight Biologics on Track to Submit LUMEVOQ® for European Approval in September 2020 Following Pre-Submission Meeting with EMA

EryDel Announces Completion of Patient Enrollment in Phase 3 ATTeST Trial the Largest Clinical Study Ever Conducted in Ataxia Telangiectasia (AT)

Shockwave Completes Enrollment of Coronary Intravascular Lithotripsy Study in Japan

Calliditas Appoints New Chief Medical Officer

RefleXion Announces First Sale of X1 Machine for Cancer Treatment

Shockwave Completes Enrollment in Pivotal Study for Coronary Intravascular Lithotripsy

Tissium Receives CE Mark and Announces Manufacturing Compliance Certification from TÜV SÜD

Calliditas strengthens its US Commercial Organization

Pixium Vision announces positive follow-up data from Prima System study in dry AMD

ProQR Announces Positive Findings From an Interim Analysis in the Phase 1/2 trial of QR-421a for Usher Syndrome and Provides Business Update

Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines